Large Trial for Metrogel 1% Competitor

Written by on March 27, 2015 in clinical trials, Metrogel 1%, prescriptions with 0 Comments

A clinical research company has posted a large clinical trial to compare a Metronidazole 1% Gel to Galderma’s Metrogel 1%.

The multi center trial is looking for 947 participants across the US.

The manufacturer of the comparison Metronidazole 1% Gel is not mentioned, but a reasonable guess would be Metronidazole Gel from Sandoz.

Generic Metronidazole 1% is available in the US from Sandoz, but scant reviews are available online.

This is good news for rosacea sufferers looking and hoping for a more affordable Metronidazole 1% Gel.

Clinical Trial NCT02393937

A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea

The purpose of this study is to compare the efficacy of two Metronidazole Gels 1%, in the treatment of Rosacea.

Sponsor: bioRASI, LLC

Primary Outcome Measures:

  • To compare the test and reference products of metronidazole topical gel 1% with regard to the mean percent change from Baseline of the inflammatory lesion counts of rosacea. [ Time Frame: 70 Days ]

Estimated Enrollment: 947

Study Start Date: February 2015

Estimated Primary Completion Date: July 2015

Participants are assigned to one of three groups in parallel for the duration of the study

Experimental: Metronidazole Gel 1%

Drug: Metronidazole Gel 1%,  Metrogel 1% Galderma S.A., and Placebo Gel.

Related Articles

About the Author

About the Author: David Pascoe started the Rosacea Support Group in October 1998. .

Follow Rosacea Support

Subscribe via RSS Feed Connect on Pinterest Connect on Google Plus

Leave your comment here


Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.